中文名称: ZLDI-8
英文名称: ZLDI-8
CAS No: 667880-38-8
分子式: C24H23N3O3S
分子量: 433.52
Z10036 ZLDI-8 ≥98% (psaitong)
包装规格:
5mg in glass bottle
溶解性:
溶于DMSO(62.5 mg/mL 超声)
产品描述:

基本信息

产品编号:

Z10036 

产品名称:

ZLDI-8

CAS:

667880-38-8

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C24H23N3O3S

溶于液体

-80℃

6个月

分子量

433.52

-20℃

1个月

化学名: 

5-[[1-[2-(2,4-Dimethylphenoxy)ethyl]-2-methylindol-3-yl]methylidene]-2-sulfanylidene-1,3-diazinane-4

Solubility (25°C):

 

体外:

 

DMSO

62.5 mg/mL (144.17mM; Need ultrasonic)

Water

 

Ethanol

 

体内(现配现用):

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.3067mL

11.5335mL

23.0670mL

5mM

0.4613mL

2.3067mL

4.6134mL

10mM

0.2307mL

1.1533mL

2.3067mL

 

生物活性

产品描述

一种 Notch 活化/裂解酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的裂解,并降低促存活/抗凋亡和上皮-间质转化相关蛋白的表达。

靶点

ADAM-17 IC50: 31.6μM (Tyrosine phosphatase)Ki: 26.22μM (Tyrosine phosphatase)

体外研究

ZLDI-8 (0.03-30 μM; 6-72 hours; MHCC97-H cells) treatment reduces cell viability in a time- and dose-dependent manner. ZLDI-8 (1-10 μM; 6-72 hours; MHCC97-H cells) significantly decreases the level of NICD and the accumulation of NICD in the nucleus. ZLDI-8 could also reduce the expression of pro-survival/anti-apoptosis regulators, Survivin and cIAP1/2. And also increases the expression of epithelial marker E-Cadherin and reduced mesenchymal markers N-Cadherin and Vimentin.ZLDI-8 enhances chemotherapy effects on tumor cell proliferation blockage, induction of apoptosis and cell-cycle arrest by inhibiting Notch pathway and blocking chemical resistance.

Cell Viability Assay

 

Cell Line:

MHCC97-H cells

Concentration:

0.03 μM, 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, 30 μM

Incubation Time:

6 hours, 12 hours, 24 hours, 48 hours, 72 hours

Result:

Emerged cytotoxic effect on MHCC97-H cells in a time- and dose-dependent manner.

Western Blot Analysis

Cell Line:

MHCC97-H cells

Concentration:

1μM, 3μM, 10μM

Incubation Time:

6 hours, 12 hours, 24 hours, 48 hours, 72 hours

Result:

Significantly decreased the level of NICD and the accumulation of NICD in the nucleus. Also reduced the expression of pro-survival/anti-apoptosis regulators, Survivin and cIAP1/2

体内研究

ZLDI-8 (0.2-2 mg/kg; intraperitoneal injection; every two days; for 20 days; nude mice) treatment enhances the effect of Sorafenib on inhibiting tumor growth in nude HCC-bearing mice model

Animal Model:

Nude mice with MHCC-97H cells

Dosage:

2 mg/kg, 1 mg/kg, 500μg/kg, or 200μg/kg

Administration:

Intraperitoneal injection; every two days; for 20 days

Result:

Inhibited tumor growth in nude HCC-bearing mice model.

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):